Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Tyson

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Journal of Robotic Surgery|December 26, 2015
Robot-assisted partial nephrectomy for complex renal massesMichael W Patton, Daniel A Salevitz, Mark D Tyson, et al.
Urology|May 28, 2013
Age-period-cohort analysis of renal cell carcinoma in United States adultsMark D Tyson, Mitchell R Humphreys, Alexander S Parker, et al.
The Canadian Journal of Urology|April 17, 2013
Marital status and prostate cancer outcomesMark D Tyson, Paul E Andrews, David A Etzioni, et al.
JAMA Internal Medicine|March 20, 2018
Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer ScreeningMatthew J Resnick, Amy J Graves, Sunita Thapa, et al.
The Journal of Urology|October 4, 2016
The Economic Implications of a Reusable Flexible Digital Ureteroscope: A Cost-Benefit AnalysisChristopher J Martin, Sean B McAdams, Haidar Abdul-Muhsin, et al.
Urology|March 3, 2012
Anatomic site-specific disparities in survival outcomes for penile squamous cell carcinomaMark D Tyson, David A Etzioni, Eric S Wisenbaugh, et al.
Journal of Endourology|September 30, 2014
The impact of ischemia on long-term renal function after partial nephrectomy in the two kidney modelDaniel A Salevitz, Michael W Patton, Mark D Tyson, et al.
The Journal of Urology|August 31, 2016
An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific SurvivalWilliam Sohn, Amy J Graves, Mark D Tyson, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Urologic Oncology|November 18, 2025
Real-world outcomes of nadofaragene firadenovec for BCG-unresponsive non-muscle-invasive bladder cancer: A multicenter experienceJacob A Moyer, Lanyu Mi, Mimi V Nguyen, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Journal of Robotic Surgery|December 26, 2015
Robot-assisted partial nephrectomy for complex renal massesMichael W Patton, Daniel A Salevitz, Mark D Tyson, et al.
Urology|May 28, 2013
Age-period-cohort analysis of renal cell carcinoma in United States adultsMark D Tyson, Mitchell R Humphreys, Alexander S Parker, et al.
The Canadian Journal of Urology|April 17, 2013
Marital status and prostate cancer outcomesMark D Tyson, Paul E Andrews, David A Etzioni, et al.
JAMA Internal Medicine|March 20, 2018
Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer ScreeningMatthew J Resnick, Amy J Graves, Sunita Thapa, et al.
The Journal of Urology|October 4, 2016
The Economic Implications of a Reusable Flexible Digital Ureteroscope: A Cost-Benefit AnalysisChristopher J Martin, Sean B McAdams, Haidar Abdul-Muhsin, et al.
Urology|March 3, 2012
Anatomic site-specific disparities in survival outcomes for penile squamous cell carcinomaMark D Tyson, David A Etzioni, Eric S Wisenbaugh, et al.
Journal of Endourology|September 30, 2014
The impact of ischemia on long-term renal function after partial nephrectomy in the two kidney modelDaniel A Salevitz, Michael W Patton, Mark D Tyson, et al.
The Journal of Urology|August 31, 2016
An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific SurvivalWilliam Sohn, Amy J Graves, Mark D Tyson, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Urologic Oncology|November 18, 2025
Real-world outcomes of nadofaragene firadenovec for BCG-unresponsive non-muscle-invasive bladder cancer: A multicenter experienceJacob A Moyer, Lanyu Mi, Mimi V Nguyen, et al.
Pageof 12